Mark A Miller Selected Research

Mark A Miller Research Topics

Disease

23	Infections 01/2018 - 07/2002
14	Human Influenza (Influenza) 12/2015 - 09/2004
10	Diarrhea 01/2019 - 03/2002
8	Clostridium Infections 03/2013 - 02/2011
7	Fatigue 11/2009 - 07/2002
3	Bone Resorption 01/2017 - 10/2010
3	Vesicular Stomatitis 02/2006 - 07/2002
2	Inflammation (Inflammations) 11/2021 - 08/2014
2	Malnutrition (Nutritional Deficiencies) 11/2017 - 11/2014
2	Measles 01/2015 - 11/2005
2	Melioidosis 08/2014 - 12/2011
2	Neoplasms (Cancer) 07/2013 - 07/2012
2	Tularemia 01/2012 - 09/2006
2	Autoimmune Diseases (Autoimmune Disease) 11/2011 - 11/2007
2	Whooping Cough (Pertussis) 03/2009 - 11/2005
2	Parkinson Disease (Parkinson's Disease) 12/2008 - 04/2007
2	Meningococcal Infections 11/2007 - 01/2005
2	Pneumonia (Pneumonitis) 06/2007 - 09/2004
2	Cholera 04/2007 - 11/2006
1	Osteolysis 03/2022
1	Cleft Lip (Harelip) 05/2020
1	Hepatitis C 01/2020
1	COVID-19 01/2020
1	Gastroesophageal Reflux (GERD) 01/2015
1	Leukocytosis (Pleocytosis) 01/2015
1	Hypoalbuminemia 01/2015
1	Communicable Diseases (Infectious Diseases) 11/2014
1	Granuloma 01/2013
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2013
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2013
1	Meningitis 11/2011

Drug/Important Bio-Agent (IBA)

20	VaccinesIBA 11/2017 - 01/2005
9	Bone Cements (Bone Glue)IBA 03/2022 - 04/2003
7	FidaxomicinIBA 07/2013 - 02/2011
6	Vancomycin FDA LinkGeneric 07/2013 - 02/2011
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 10/2004
4	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2015 - 10/2007
4	Proteins (Proteins, Gene)FDA Link 08/2007 - 07/2002
3	Pharmaceutical PreparationsIBA 01/2020 - 02/2013
3	Antiviral Agents (Antivirals)IBA 12/2014 - 01/2012
3	AntibodiesIBA 11/2011 - 11/2007
2	Biological ProductsIBA 11/2021 - 02/2012
2	AlbuminsIBA 07/2013 - 08/2012
2	CytokinesIBA 01/2013 - 08/2011
2	InflammasomesIBA 12/2011 - 08/2011
2	Polysaccharides (Glycans)IBA 11/2011 - 11/2007
2	ElementsIBA 11/2009 - 07/2002
2	Immunoglobulin G (IgG)IBA 03/2009 - 03/2009
2	Polymethyl Methacrylate (Sol)IBA 10/2008 - 07/2002
2	Interleukin-12 (IL 12)IBA 02/2006 - 07/2002
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	PapainIBA 01/2020
1	Nucleic AcidsIBA 01/2019
1	LipidsIBA 01/2018
1	lysophosphatidic acidIBA 01/2018
1	Cholera ToxinIBA 01/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2015
1	AcidsIBA 01/2015
1	CreatinineIBA 01/2015
1	Tripartite Motif ProteinsIBA 12/2014
1	Viral RNAIBA 12/2014
1	EnzymesIBA 08/2014
1	BradykininIBA 08/2014
1	Pancreatic Elastase (Elastase)IBA 08/2014
1	Leukocyte Elastase (Neutrophil Elastase)IBA 08/2014
1	Bradykinin Receptor AntagonistsIBA 08/2014
1	AntigensIBA 01/2013
1	Pattern Recognition ReceptorsIBA 01/2013
1	Interleukin-17 (Interleukin 17)IBA 01/2013
1	RiboswitchIBA 11/2012
1	Virulence Factors (Pathogenicity Factors)IBA 11/2012
1	Green Fluorescent ProteinsIBA 11/2012
1	Theophylline (Theon)FDA LinkGeneric 11/2012
1	Capsules (Microcapsules)IBA 11/2012
1	Lipid AIBA 11/2012
1	O Antigens (O Antigen)IBA 11/2012
1	Biotin (Vitamin H)FDA Link 10/2012
1	Cisplatin (Platino)FDA LinkGeneric 07/2012
1	Copper Transporter 1IBA 07/2012
1	Proton Pump InhibitorsIBA 07/2012
1	NLR ProteinsIBA 12/2011
1	Interleukin-18 (Interleukin 18)IBA 12/2011
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 12/2011
1	polysialic acidIBA 11/2011
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 11/2011
1	ChemokinesIBA 08/2011
1	Attenuated VaccinesIBA 08/2011
1	nucleic acid probe 1IBA 06/2011
1	aluminum sulfate (alum)IBA 10/2009
1	avian influenza A virus hemagglutininIBA 10/2009
1	Pertussis ToxinIBA 03/2009
1	pertussis toxoidIBA 03/2009

Therapy/Procedure

7	Therapeutics 01/2020 - 08/2005
2	Oral Administration 01/2018 - 08/2012
2	Hip Replacement Arthroplasty (Total Hip Replacement) 10/2010 - 05/2004
1	Alveolar Bone Grafting 05/2020
1	Injections 01/2018
1	Fluid Therapy (Oral Rehydration Therapy) 01/2018
1	Anesthesia 01/2012
1	Aftercare (After-Treatment) 02/2011